The early detection and treatment of people at risk for psychosis is currently regarded as a promising strategy in fighting the devastating consequences of psychotic disorders. Currently, the 2 most broadly used sets of at-risk criteria, that is, ultra-high risk (UHR) and basic symptom criteria, were developed mainly in adult samples. We review the data regarding the presence and relevance of at-risk symptoms for psychosis in children and adolescents. The few existing studies suggest that attenuated psychotic symptoms (APS) and brief limited intermittent psychotic symptoms (BLIPS) do have some clinical relevance in young adolescents from the general population. Nevertheless, their differentiation from atypical psychotic symptoms or an emerging schizotypal personality disorder, as well as their stability and predictive accuracy for psychosis, are still unclear. Further, standard interviews for UHR criteria do not define a minimum age for the assessment of APS and BLIPS or guidelines as to when and how to include information from parents. APS and basic symptoms may be predictive of conversion to psychosis in help-seeking young adolescents. Nevertheless, the rate and timing, and thus the required observation time, need further study. Moreover, no study has yet addressed the issue of how to treat children and adolescents presenting with at-risk symptoms and criteria. Further research is urgently needed to examine if current at-risk criteria and approaches have to be tailored to the special needs of children and adolescents. A preliminary rationale for how to deal with at-risk symptoms for psychosis in clinical practice is provided.
World Health Organization (WHO)Prevention of mental disorders. Geneva (CH): WHO; 2004.
2.
AsarnowJRTompsonMWooS, Is expressed emotion a specific risk factor for depression or a nonspecific correlate of psychopathology?J Abnorm Child Psychol. 2001;29(6):573–583.
3.
JoaIJohannessenJOLangeveldJ, Baseline profiles of adolescent vs adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand. 2009;119(6):494–500.
4.
BallageerTMallaAManchandaR, Is adolescent-onset first-episode psychosis different from adult onset?J Am Acad Child Adolesc Psychiatry. 2005;44(8):782–789.
5.
BassoMRNasrallahHAOlsonSC, Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10(2):107–112.
6.
CorrellCUCarlsonHE. Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47:9–20.
7.
De HertMDobbelaereMSheridanEM, Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011;26(3): 144–158.
8.
FleischhakerCSchulzETepperK, Long-term course of adolescent schizophrenia. Schizophr Bull. 2005;31(3):769–780.
9.
ReichertAKreikerSMehler-WexC, The psychopathological and psychosocial outcome of early-onset schizophrenia: Preliminary data of a 13-year follow-up. Child Adolesc Psychiatry Ment Health. 2008;2(1):6.
10.
AmmingerGPHenryLPHarriganSM, Outcome in early-onset schizophrenia revisited: Findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Schizophr Res. 2011;131(1–3):112–119.
11.
SchimmelmannBGConusPCottonS, Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res. 2007;95(1–3):1–8.
12.
McGorryPDEdwardsJMihalopoulosC, EPPIC: An evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305–326.
13.
JohannessenJOJoaIAuestadB, First-episode psychosis patients recruited into treatment via early detection teams versus ordinary pathways: Course and health service use during 5 years. Early Interv Psychiatry. 2011;5(1):70–75.
14.
NordentoftMJeppesenPPetersenL, The rationale for early intervention in schizophrenia and related disorders. Early Interv Psychiatry. 2009;3(Suppl 1):3–7.
15.
HäfnerHNowotnyBLöfflerW, When and how does schizophrenia produce social deficits?Eur Arch Psychiatry ClinNeurosci. 1995;246:17–28.
16.
Schultze-LutterFRuhrmannSBerningJ, Basic symptoms and ultrahigh risk criteria: Symptom development in the initial prodromal state. Schizophr Bull. 2010;36(1):182–191.
17.
Schultze-LutterFReschFKochE, [Early detection of psychosis in children and adolescents—have developmental particularities been sufficiently considered?]. Z Kinder Jugendpsychiatr Psychother. 2011;39(5):301–311. German.
18.
PhillipsLJYungARMcGorryPD. Identification of young people at risk of psychosis: Validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust N Z J Psychiatry. 2000;34(Suppl):S164–S169.
19.
Schultze-LutterFSchimmelmannBGRuhrmannS.The near Babylonian speech confusion in early detection of psychosis. Schizophr Bull. 2011;37(4):653–655.
20.
Schultze-LutterFSchimmelmannBGRuhrmannS, “Arose is a rose is a rose,” but at-risk criteria differ. Psychopathology. 2012 Aug 15; Epub ahead of print.
21.
KlosterkötterJHeimlichMSteinmeyerEM, Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58(2):158–164.
22.
Schultze-LutterFRuhrmannSKlosterkötterJ.Can schizophrenia be predicted phenomenologically? In: JohannessenJOMertindaleBCullbergJ, editors. Evolving psychosis, different stages, different treatments. London (GB): Routledge; 2006. p104–123.
23.
Schultze-LutterFAddingtonJRuhrmannS, The Schizophrenia Proneness Instrument, Adult version (SPI-A). Rome (IT): Giovanni Fioriti Editore; 2007.
KelleherIMurtaghAMolloyC, Identification and characterization of prodromal risk syndromes in young adolescents in the community: A population-based clinical interview study. Schizophr Bull. 2012;38(2):239–246.
28.
MengHSchimmelmannBGKochE, Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents. Schizophr Res. 2009;111(1–3):32–38.
29.
Schultze-LutterFRuhrmannSFusar-PoliP, Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des. 2012;18(4):351–357.
30.
PoultonRCaspiAMoffittTE, Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Arch Gen Psychiatry. 2000;57(11):1053–1058.
31.
HlastalaSAMcClellanJ.Phenomenology and diagnostic stability of youths with atypical psychotic symptoms. J Child Adolesc Psychopharmacol. 2005;15(3):497–509.
32.
Bartels-VelthuisAAJennerJAvan de WilligeG, Prevalence and correlates of auditory vocal hallucinations in middle childhood. Br J Psychiatry. 2010;196(1):41–46.
33.
Bartels-VelthuisAAvan de WilligeGJennerJA, Course of auditory vocal hallucinations in childhood: 5-year follow-up study. Br J Psychiatry. 2011;199(4):296–302.
34.
American Psychiatric Association (APA)Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): APA; 1994.
35.
JonesPB. Risk factors for schizophrenia in childhood and youth. In: HäfnerH, editor. Risk and protective factors in schizophrenia. Towards a conceptual model of the disease process. Darmstadt (DE): Steinkopff; 2002. p 141–162.
36.
EsterbergMLGouldingSMWalkerEF. A personality disorders: Schizotypal, schizoid and paranoid personality disorders in childhood and adolescence. J Psychopathol Behav Assess. 2010;32(4):515–528.
37.
WalderDJMittalVTrotmanHD, Neurocognition and conversion to psychosis in adolescents at high-risk. Schizophr Res. 2008;101(1–3):161–168.
38.
OerterRMontadaL.Entwicklungspsychologie. Weinheim (DE): Beltz Psychologie Verlags Union; 2008. German.
39.
Schultze-LutterFMarshallMKochE.Schizophrenia Proneness Instrument, Child and Youth version (SPI-CY). Extended English translation. Rome (IT): Giovanni Fioriti Editore; 2012.
40.
KochESchultze-LutterFSchimmelmannBG, On the importance and detection of prodromal symptoms from the perspective of child and adolescent psychiatry. Clin Neuropsychiatry. 2010;7:38–48.
41.
CannonTDCadenheadKCornblattB, Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28–37.
42.
RuhrmannSSchultze-LutterFSalokangasRKR, Prediction of psychosis in adolescents and young adults at high risk: Results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010;67(3):241–251.
43.
SchlosserDAJacobsonSChenQ, Recovery from an at-risk state: Clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull. 2012;38(6):1225–1233.
44.
CornblattBALenczTSmithCW, Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007;68(4):546–557.
45.
ZiermansTBSchothorstPFSprongM, Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res. 2011;126(1–3):58–64.
46.
CorrellCULenczTSmithCW, Prospective study of adolescents with subsyndromal psychosis: Characteristics and outcome. J Child Adolesc Psychopharmacol. 2005;15(3):418–433.
47.
CorrellCUSmithCWAutherAM, Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol. 2008;18(5):475–490.
48.
Castro-FornielesJParelladaMGonzalez-PintoA, The Child and Adolescent First-Episode Psychosis Study (CAFEPS): Design and baseline results. Schizophr Res. 2007;91(1–3):226–237.
49.
PeralaJSuvisaariJSaarniSI, Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64(1): 19–28.
50.
SchimmelmannBGPaulusSSchachtM, Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. J Child Adolesc Psychopharmacol. 2005;15(2):249–258.
51.
De HertMDobbelaereMSheridanEM, Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011;26(3):144–158.
52.
SchimmelmannBG. [Early detection of psychoses—weighing risks and benefits in children and adolescents]. Z Kinder Jugendpsychiatr Psychother. 2011;39(5):297–299. German.
